Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
Clinical trial NCT05775471 · RECRUITING
Trial details
- NCT number
- NCT05775471
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2027-01-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.